04.06.2013 Views

GHS Classification Guidance for the Japanese Government

GHS Classification Guidance for the Japanese Government

GHS Classification Guidance for the Japanese Government

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

*As <strong>for</strong> substances of which only mixture data are available (provided mixed or diluted<br />

with solvents without toxicity), <strong>the</strong>ir <strong>GHS</strong> classification as pure substances are<br />

per<strong>for</strong>med by estimating from concentrations appropriately, and <strong>the</strong> estimation<br />

processes are to be described as a ground <strong>for</strong> classification.<br />

B) Regarding classification procedure<br />

1) Substances meeting [Decision criteria 1a] or [Decision criteria 1b] below are placed in<br />

Category 1.<br />

[Decision criteria 1a]: Substances <strong>for</strong> which evidence of inducing toxic effects in humans are<br />

(Notes)<br />

available in List 1.<br />

a) Effects on organs that are obviously known to be secondary effects shall be excluded<br />

from <strong>the</strong> description. Judgement by expert’s shall be sought <strong>for</strong> where necessary about<br />

whe<strong>the</strong>r <strong>the</strong> effects are secondary effects or not. When such a judgment is difficult, all<br />

organs affected shall be cited.<br />

b) Effects on respiratory system by site of contact are included here, and are placed in<br />

Category 1 (pneumoconiosis, etc.). However, such effects by site of contact o<strong>the</strong>r than<br />

respiratory tract, <strong>for</strong> example, irritation/inflammation reaction in digestive system in a<br />

case of oral administration of a corrosive/irritant, are considered to be subsumed under<br />

o<strong>the</strong>r toxicity items such as skin corrosion and are not classified into specific target<br />

organ.<br />

c) When only minimal symptoms (slight fever, languor, etc.)are described, <strong>the</strong> substance is<br />

placed in “Not classified”.<br />

d) All organs described as affected in List 1 shall be indicated. However, when organs<br />

listed in multiple assessment documents based on <strong>the</strong> same type of tests are not <strong>the</strong><br />

same, indicate <strong>the</strong> commonly listed organs. When a toxic symptom alone is described<br />

and <strong>the</strong> affected organ cannot be identified, put “systemic toxicity” instead. When <strong>the</strong><br />

target organ is identified, fundamentally, description of toxic symptom is not required.<br />

e) When <strong>the</strong> affected organ can be identified, indicate <strong>the</strong> applicable category along with<br />

<strong>the</strong> affected organs given in paren<strong>the</strong>ses are indicated in “<strong>GHS</strong> classification”. When <strong>the</strong><br />

affected organ cannot be identified, put “systemic toxicity” in paren<strong>the</strong>ses.<br />

[Decision criteria 1b]: Animal tests meeting all of conditions below<br />

a) Any animal species is applicable<br />

b) Exposure amount is identified and is induced within <strong>the</strong> guidance value range of<br />

Category 1<br />

c) The test is described in List 1 or an OECD TG test in List 2, is according to GLP, and<br />

185

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!